Tradewinds Capital Management’s Editas Medicine EDIT Stock Holding History

Tradewinds Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.27K	Hold	700	–	–	﹤0.01%	551
2026 Q1	$1.73K	Hold	700	–	–	﹤0.01%	574
2025 Q4	$1.44K	Hold	700	–	–	﹤0.01%	558
2025 Q3	$2.43K	Hold	700	–	–	﹤0.01%	500
2025 Q2	$1.54K	Hold	700	–	–	﹤0.01%	494
2025 Q1	$812	Buy	+700	New	+$1.03K	﹤0.01%	553
2020 Q3	–	Sell	-100	Closed	-$3K	–	674
2020 Q2	$3K	Hold	100	–	–	﹤0.01%	521
2020 Q1	$2K	Sell	100 -34	-25%	-$858	﹤0.01%	537
2019 Q4	$4K	Buy	134 +34	+34%	+$849	﹤0.01%	517
2019 Q3	$2K	Hold	100	–	–	﹤0.01%	529
2019 Q2	$2K	Hold	100	–	–	﹤0.01%	524
2019 Q1	$2K	Sell	100 -177	-64%	-$4.01K	﹤0.01%	532
2018 Q4	$6K	Hold	277	–	–	﹤0.01%	447
2018 Q3	$9K	Hold	277	–	–	﹤0.01%	424
2018 Q2	$10K	Hold	277	–	–	﹤0.01%	413
2018 Q1	$9K	Hold	277	–	–	﹤0.01%	414
2017 Q4	$9K	Hold	277	–	–	﹤0.01%	435
2017 Q3	$7K	Hold	277	–	–	﹤0.01%	440
2017 Q2	$5K	Hold	277	–	–	﹤0.01%	477
2017 Q1	$6K	Hold	277	–	–	﹤0.01%	459
2016 Q4	$4K	Sell	277 -376	-58%	-$5.71K	﹤0.01%	458
2016 Q3	$9K	Hold	653	–	–	0.01%	385
2016 Q2	$16K	Buy	653 +603	+1,206%	+$20.3K	0.01%	317
2016 Q1	$2K	Buy	+50	New	+$1.31K	﹤0.01%	546

Other funds holding EDIT

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Tradewinds Capital Management's EDIT Position: Q2 2026 in Review

Tradewinds Capital Management held its Editas Medicine (EDIT) position steady in Q2 2026 at 700 shares worth $2.27K. The position accounts for ﹤0.01% of the portfolio, ranked #551.

Tradewinds Capital Management first reported a position in EDIT in Q1 2016 and has held it in 24 quarters since. The position peaked at $16K in Q2 2016. 216 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

Tradewinds Capital Management held 700 shares of Editas Medicine worth $2.27K as of Q2 2026.
Tradewinds Capital Management left its Editas Medicine share count unchanged in Q2 2026.
Editas Medicine made up ﹤0.01% of Tradewinds Capital Management's portfolio in Q2 2026, its #551 holding.
Tradewinds Capital Management first reported a position in Editas Medicine in Q1 2016 and has held it in 24 quarters since.
Tradewinds Capital Management's Editas Medicine position peaked at $16K in Q2 2016.
216 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Tradewinds Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.